Clinical Trial Update: Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma [Phase 2]

View source ↗

Summary

This Clinical Trial Update reports a Phase 2 safety and tolerability comparison between Levalbuterol HFA and Racemic Albuterol HFA in individuals with asthma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Levalbuterol HFA (levalbuterol)
• Racemic Albuterol HFA (albuterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED